Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Morgan Stanley to hold a virtual conference » 04:55
09/15/21
09/15
04:55
09/15/21
04:55
ABC

AmerisourceBergen

$123.06 /

-0.61 (-0.49%)

, ACCD

Accolade

$46.70 /

-0.58 (-1.23%)

, AKBA

Akebia

$2.75 /

-0.165 (-5.66%)

, CMPS

Compass Pathways

$31.95 /

-1.1 (-3.33%)

, GH

Guardant Health

$127.03 /

+0.56 (+0.44%)

, KLDO

Kaleido Biosciences

$5.48 /

-0.045 (-0.81%)

, YMAB

Y-mAbs Therapeutics

$33.27 /

-0.05 (-0.15%)

, RYTM

Rhythm Pharmaceuticals

$12.30 /

-0.75 (-5.75%)

, OCDX

Ortho Clinical Diagnostics

$18.64 /

-0.08 (-0.43%)

, KDNY

Chinook Therapeutics

$12.78 /

-0.26 (-1.99%)

, IRTC

iRhythm

$61.34 /

-3.65 (-5.62%)

, NSTG

NanoString

$56.01 /

-0.16 (-0.28%)

, RMD

ResMed

$292.26 /

+3.15 (+1.09%)

, RDY

Dr. Reddy's

$66.87 /

-0.2 (-0.30%)

, HOLX

Hologic

$78.05 /

-0.49 (-0.62%)

, EXEL

Exelixis

$20.14 /

-0.11 (-0.54%)

, FHTX

Foghorn Therapeutics

$12.33 /

-0.67 (-5.15%)

, MAYNF

Mayne Pharma

/

+

, RCM

R1 RCM

$20.24 /

-0.17 (-0.83%)

, TIL

Instil Bio

$16.45 /

-1.28 (-7.22%)

, SNDX

Syndax

$19.00 /

+0.16 (+0.85%)

, SHCR

Sharecare

$8.02 /

-0.15 (-1.84%)

19th Annual Global…

19th Annual Global Healthcare Virtual Conference to be held on September 9-10 and will resume on September 13-15. Webcast Link

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$33.27 /

-0.05 (-0.15%)

TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

SNDX Syndax
$19.00 /

+0.16 (+0.85%)

SHCR Sharecare
$8.02 /

-0.15 (-1.84%)

RYTM Rhythm Pharmaceuticals
$12.30 /

-0.75 (-5.75%)

RMD ResMed
$292.26 /

+3.15 (+1.09%)

RDY Dr. Reddy's
$66.87 /

-0.2 (-0.30%)

RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

OCDX Ortho Clinical Diagnostics
$18.64 /

-0.08 (-0.43%)

NSTG NanoString
$56.01 /

-0.16 (-0.28%)

KLDO Kaleido Biosciences
$5.48 /

-0.045 (-0.81%)

KDNY Chinook Therapeutics
$12.78 /

-0.26 (-1.99%)

IRTC iRhythm
$61.34 /

-3.65 (-5.62%)

HOLX Hologic
$78.05 /

-0.49 (-0.62%)

GH Guardant Health
$127.03 /

+0.56 (+0.44%)

FHTX Foghorn Therapeutics
$12.33 /

-0.67 (-5.15%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

CMPS Compass Pathways
$31.95 /

-1.1 (-3.33%)

AKBA Akebia
$2.75 /

-0.165 (-5.66%)

ACCD Accolade
$46.70 /

-0.58 (-1.23%)

ABC AmerisourceBergen
$123.06 /

-0.61 (-0.49%)

ABC AmerisourceBergen
$123.06 /

-0.61 (-0.49%)

08/27/21 Baird
AmerisourceBergen a table pounding top pick, says Baird
08/05/21 Credit Suisse
AmerisourceBergen price target raised to $144 from $132 at Credit Suisse
08/05/21 Baird
AmerisourceBergen price target raised to $162 from $156 at Baird
07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
ACCD Accolade
$46.70 /

-0.58 (-1.23%)

07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
07/09/21 Needham
Accolade price target raised to $68 from $59 at Needham
07/09/21 Stifel
Accolade price target raised to $64 from $54 at Stifel
07/09/21 Piper Sandler
Accolade has 'multiple beat-and-raise drivers,' says Piper Sandler
AKBA Akebia
$2.75 /

-0.165 (-5.66%)

07/15/21 Piper Sandler
Akebia approval path intact after FibroGen panel vote, says Piper Sandler
07/14/21 Morgan Stanley
FibroGen AdCom docs have likely read through for Akebia, says Morgan Stanley
06/01/21 H.C. Wainwright
Akebia NDA accepted with no FDA panel planned, says H.C. Wainwright
06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
CMPS Compass Pathways
$31.95 /

-1.1 (-3.33%)

07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$127.03 /

+0.56 (+0.44%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
KLDO Kaleido Biosciences
$5.48 /

-0.045 (-0.81%)

07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
YMAB Y-mAbs Therapeutics
$33.27 /

-0.05 (-0.15%)

06/28/21 H.C. Wainwright
Y-mAbs Therapeutics price target lowered to $68 from $70 at H.C. Wainwright
05/07/21 BofA
Y-mAbs Therapeutics upgraded to Buy from Neutral at BofA
04/23/21 Cowen
Y-mAbs Therapeutics transferred with Outperform at Cowen
04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
RYTM Rhythm Pharmaceuticals
$12.30 /

-0.75 (-5.75%)

09/14/21 Goldman Sachs
Rhythm Pharmaceuticals assumed with Neutral from Sell at Goldman Sachs
08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Ladenburg
Rhythm Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
OCDX Ortho Clinical Diagnostics
$18.64 /

-0.08 (-0.43%)

08/05/21 Piper Sandler
Piper ups Ortho Clinical Diagnostics target to $29, says to buy on any weakness
08/05/21 JPMorgan
Ortho Clinical price target raised to $28 from $25 at JPMorgan
08/05/21 H.C. Wainwright
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright
08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
KDNY Chinook Therapeutics
$12.78 /

-0.26 (-1.99%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
IRTC iRhythm
$61.34 /

-3.65 (-5.62%)

09/13/21 Baird
iRhythm's new COE has 'quality pedigree,' says Baird
09/13/21 Piper Sandler
DexCom COO departure won't affect momentum, says Piper Sandler
08/26/21 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
08/06/21 Citi
iRhythm price target lowered to $55 from $74 at Citi
NSTG NanoString
$56.01 /

-0.16 (-0.28%)

03/02/21 JPMorgan
NanoString price target raised to $80 from $75 at JPMorgan
03/02/21 Baird
NanoString price target raised to $78 from $70 at Baird
01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
RMD ResMed
$292.26 /

+3.15 (+1.09%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RDY Dr. Reddy's
$66.87 /

-0.2 (-0.30%)

07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral at Credit Suisse after Q1 report
07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Investec
Dr. Reddy's upgraded to Buy from Hold at Investec
02/02/21 Barclays
Dr. Reddy's upgraded to Overweight from Equal Weight at Barclays
HOLX Hologic
$78.05 /

-0.49 (-0.62%)

07/06/21 Evercore ISI
Evercore ISI upgrades Hologic to Outperform on visibility in base business
07/06/21 Evercore ISI
Hologic upgraded to Outperform from In Line at Evercore ISI
06/11/21 Citi
Hologic 15% selloff brings 'strong entry point,' says Citi
04/29/21 Citi
Hologic price target lowered to $80 from $90 at Citi
EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FHTX Foghorn Therapeutics
$12.33 /

-0.67 (-5.15%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
MAYNF Mayne Pharma
/

+

08/30/21 Citi
Mayne Pharma upgraded to Buy from Neutral at Citi
RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
SNDX Syndax
$19.00 /

+0.16 (+0.85%)

06/03/21 Baird
Syndax transferred with Outperform at Baird
05/25/21 Citi
Syndax initiated with a Buy at Citi
04/21/21 Baird
Syndax price target lowered to $30 from $39 at Baird
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
SHCR Sharecare
$8.02 /

-0.15 (-1.84%)

09/13/21 BTIG
Sharecare recent selloff creates buying opportunity, says BTIG
08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
08/04/21 Canaccord
Sharecare initiated with a Buy at Canaccord
07/28/21 BTIG
Sharecare initiated with a Buy at BTIG
YMAB Y-mAbs Therapeutics
$33.27 /

-0.05 (-0.15%)

TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

SNDX Syndax
$19.00 /

+0.16 (+0.85%)

SHCR Sharecare
$8.02 /

-0.15 (-1.84%)

RYTM Rhythm Pharmaceuticals
$12.30 /

-0.75 (-5.75%)

RMD ResMed
$292.26 /

+3.15 (+1.09%)

RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

OCDX Ortho Clinical Diagnostics
$18.64 /

-0.08 (-0.43%)

NSTG NanoString
$56.01 /

-0.16 (-0.28%)

KLDO Kaleido Biosciences
$5.48 /

-0.045 (-0.81%)

KDNY Chinook Therapeutics
$12.78 /

-0.26 (-1.99%)

IRTC iRhythm
$61.34 /

-3.65 (-5.62%)

HOLX Hologic
$78.05 /

-0.49 (-0.62%)

GH Guardant Health
$127.03 /

+0.56 (+0.44%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

CMPS Compass Pathways
$31.95 /

-1.1 (-3.33%)

AKBA Akebia
$2.75 /

-0.165 (-5.66%)

ACCD Accolade
$46.70 /

-0.58 (-1.23%)

ABC AmerisourceBergen
$123.06 /

-0.61 (-0.49%)

  • 10
    Sep
  • 10
    Jun
  • 27
    May
  • 30
    Apr
  • 19
    Mar
  • 18
    Feb
  • 04
    Feb
  • 05
    Feb
  • 28
    Jan
  • 09
    Dec
  • 22
    Oct
  • 23
    Oct
  • 07
    Oct
  • 08
    Oct
  • 18
    Sep
RDY Dr. Reddy's
$66.87 /

-0.2 (-0.30%)

IRTC iRhythm
$61.34 /

-3.65 (-5.62%)

CMPS Compass Pathways
$31.95 /

-1.1 (-3.33%)

ABC AmerisourceBergen
$123.06 /

-0.61 (-0.49%)

TIL Instil Bio
$16.45 /

-1.28 (-7.22%)

SNDX Syndax
$19.00 /

+0.16 (+0.85%)

RYTM Rhythm Pharmaceuticals
$12.30 /

-0.75 (-5.75%)

RMD ResMed
$292.26 /

+3.15 (+1.09%)

RCM R1 RCM
$20.24 /

-0.17 (-0.83%)

OCDX Ortho Clinical Diagnostics
$18.64 /

-0.08 (-0.43%)

KDNY Chinook Therapeutics
$12.78 /

-0.26 (-1.99%)

IRTC iRhythm
$61.34 /

-3.65 (-5.62%)

HOLX Hologic
$78.05 /

-0.49 (-0.62%)

GH Guardant Health
$127.03 /

+0.56 (+0.44%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

CMPS Compass Pathways
$31.95 /

-1.1 (-3.33%)

AKBA Akebia
$2.75 /

-0.165 (-5.66%)

ACCD Accolade
$46.70 /

-0.58 (-1.23%)

ABC AmerisourceBergen
$123.06 /

-0.61 (-0.49%)

SHCR Sharecare
$8.02 /

-0.15 (-1.84%)

RMD ResMed
$292.26 /

+3.15 (+1.09%)

HOLX Hologic
$78.05 /

-0.49 (-0.62%)

FHTX Foghorn Therapeutics
$12.33 /

-0.67 (-5.15%)

ACCD Accolade
$46.70 /

-0.58 (-1.23%)

ABC AmerisourceBergen
$123.06 /

-0.61 (-0.49%)

Conference/Events
Morgan Stanley to hold a virtual conference » 04:55
09/14/21
09/14
04:55
09/14/21
04:55
ABC

AmerisourceBergen

$123.66 /

+0.79 (+0.64%)

, ACCD

Accolade

$47.23 /

-0.1 (-0.21%)

, AKBA

Akebia

$2.92 /

+0.035 (+1.22%)

, CMPS

Compass Pathways

$33.05 /

-1.24 (-3.62%)

, GH

Guardant Health

$126.51 /

-2.58 (-2.00%)

, KLDO

Kaleido Biosciences

$5.53 /

-0.015 (-0.27%)

, YMAB

Y-mAbs Therapeutics

$33.32 /

+0.25 (+0.76%)

, RYTM

Rhythm Pharmaceuticals

$13.06 /

+0.07 (+0.54%)

, OCDX

Ortho Clinical Diagnostics

$18.72 /

+0.4 (+2.18%)

, KDNY

Chinook Therapeutics

$13.05 /

-0.04 (-0.31%)

, IRTC

iRhythm

$64.99 /

+16.465 (+33.93%)

, NSTG

NanoString

$56.17 /

-3.51 (-5.88%)

, RMD

ResMed

$289.12 /

-6.46 (-2.19%)

, RDY

Dr. Reddy's

$67.09 /

+1.18 (+1.79%)

, HOLX

Hologic

$78.49 /

-1.51 (-1.89%)

, EXEL

Exelixis

$20.25 /

+0.275 (+1.38%)

, FHTX

Foghorn Therapeutics

$12.67 /

-1.43 (-10.14%)

, MAYNF

Mayne Pharma

/

+

, RCM

R1 RCM

$20.41 /

+0.285 (+1.42%)

, TIL

Instil Bio

$18.09 /

-0.78 (-4.13%)

, SNDX

Syndax

$18.84 /

+0.54 (+2.95%)

, SHCR

Sharecare

$8.17 /

+0.16 (+2.00%)

19th Annual Global…

19th Annual Global Healthcare Virtual Conference to be held on September 9-10 and will resume on September 13-15. Webcast Link

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$33.32 /

+0.25 (+0.76%)

TIL Instil Bio
$18.09 /

-0.78 (-4.13%)

SNDX Syndax
$18.84 /

+0.54 (+2.95%)

SHCR Sharecare
$8.17 /

+0.16 (+2.00%)

RYTM Rhythm Pharmaceuticals
$13.06 /

+0.07 (+0.54%)

RMD ResMed
$289.12 /

-6.46 (-2.19%)

RDY Dr. Reddy's
$67.09 /

+1.18 (+1.79%)

RCM R1 RCM
$20.41 /

+0.285 (+1.42%)

OCDX Ortho Clinical Diagnostics
$18.72 /

+0.4 (+2.18%)

NSTG NanoString
$56.17 /

-3.51 (-5.88%)

KLDO Kaleido Biosciences
$5.53 /

-0.015 (-0.27%)

KDNY Chinook Therapeutics
$13.05 /

-0.04 (-0.31%)

IRTC iRhythm
$64.99 /

+16.465 (+33.93%)

HOLX Hologic
$78.49 /

-1.51 (-1.89%)

GH Guardant Health
$126.51 /

-2.58 (-2.00%)

FHTX Foghorn Therapeutics
$12.67 /

-1.43 (-10.14%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

CMPS Compass Pathways
$33.05 /

-1.24 (-3.62%)

AKBA Akebia
$2.92 /

+0.035 (+1.22%)

ACCD Accolade
$47.23 /

-0.1 (-0.21%)

ABC AmerisourceBergen
$123.66 /

+0.79 (+0.64%)

ABC AmerisourceBergen
$123.66 /

+0.79 (+0.64%)

08/27/21 Baird
AmerisourceBergen a table pounding top pick, says Baird
08/05/21 Credit Suisse
AmerisourceBergen price target raised to $144 from $132 at Credit Suisse
08/05/21 Baird
AmerisourceBergen price target raised to $162 from $156 at Baird
07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
ACCD Accolade
$47.23 /

-0.1 (-0.21%)

07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
07/09/21 Needham
Accolade price target raised to $68 from $59 at Needham
07/09/21 Stifel
Accolade price target raised to $64 from $54 at Stifel
07/09/21 Piper Sandler
Accolade has 'multiple beat-and-raise drivers,' says Piper Sandler
AKBA Akebia
$2.92 /

+0.035 (+1.22%)

07/15/21 Piper Sandler
Akebia approval path intact after FibroGen panel vote, says Piper Sandler
07/14/21 Morgan Stanley
FibroGen AdCom docs have likely read through for Akebia, says Morgan Stanley
06/01/21 H.C. Wainwright
Akebia NDA accepted with no FDA panel planned, says H.C. Wainwright
06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
CMPS Compass Pathways
$33.05 /

-1.24 (-3.62%)

07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$126.51 /

-2.58 (-2.00%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
KLDO Kaleido Biosciences
$5.53 /

-0.015 (-0.27%)

07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
YMAB Y-mAbs Therapeutics
$33.32 /

+0.25 (+0.76%)

06/28/21 H.C. Wainwright
Y-mAbs Therapeutics price target lowered to $68 from $70 at H.C. Wainwright
05/07/21 BofA
Y-mAbs Therapeutics upgraded to Buy from Neutral at BofA
04/23/21 Cowen
Y-mAbs Therapeutics transferred with Outperform at Cowen
04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
RYTM Rhythm Pharmaceuticals
$13.06 /

+0.07 (+0.54%)

08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Ladenburg
Rhythm Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
OCDX Ortho Clinical Diagnostics
$18.72 /

+0.4 (+2.18%)

08/05/21 Piper Sandler
Piper ups Ortho Clinical Diagnostics target to $29, says to buy on any weakness
08/05/21 JPMorgan
Ortho Clinical price target raised to $28 from $25 at JPMorgan
08/05/21 H.C. Wainwright
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright
08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
KDNY Chinook Therapeutics
$13.05 /

-0.04 (-0.31%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
IRTC iRhythm
$64.99 /

+16.465 (+33.93%)

09/13/21 Baird
iRhythm's new COE has 'quality pedigree,' says Baird
09/13/21 Piper Sandler
DexCom COO departure won't affect momentum, says Piper Sandler
08/26/21 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
08/06/21 Citi
iRhythm price target lowered to $55 from $74 at Citi
NSTG NanoString
$56.17 /

-3.51 (-5.88%)

03/02/21 JPMorgan
NanoString price target raised to $80 from $75 at JPMorgan
03/02/21 Baird
NanoString price target raised to $78 from $70 at Baird
01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
RMD ResMed
$289.12 /

-6.46 (-2.19%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RDY Dr. Reddy's
$67.09 /

+1.18 (+1.79%)

07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral at Credit Suisse after Q1 report
07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Investec
Dr. Reddy's upgraded to Buy from Hold at Investec
02/02/21 Barclays
Dr. Reddy's upgraded to Overweight from Equal Weight at Barclays
HOLX Hologic
$78.49 /

-1.51 (-1.89%)

07/06/21 Evercore ISI
Evercore ISI upgrades Hologic to Outperform on visibility in base business
07/06/21 Evercore ISI
Hologic upgraded to Outperform from In Line at Evercore ISI
06/11/21 Citi
Hologic 15% selloff brings 'strong entry point,' says Citi
04/29/21 Citi
Hologic price target lowered to $80 from $90 at Citi
EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FHTX Foghorn Therapeutics
$12.67 /

-1.43 (-10.14%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
MAYNF Mayne Pharma
/

+

08/30/21 Citi
Mayne Pharma upgraded to Buy from Neutral at Citi
RCM R1 RCM
$20.41 /

+0.285 (+1.42%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
TIL Instil Bio
$18.09 /

-0.78 (-4.13%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
SNDX Syndax
$18.84 /

+0.54 (+2.95%)

06/03/21 Baird
Syndax transferred with Outperform at Baird
05/25/21 Citi
Syndax initiated with a Buy at Citi
04/21/21 Baird
Syndax price target lowered to $30 from $39 at Baird
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
SHCR Sharecare
$8.17 /

+0.16 (+2.00%)

09/13/21 BTIG
Sharecare recent selloff creates buying opportunity, says BTIG
08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
08/04/21 Canaccord
Sharecare initiated with a Buy at Canaccord
07/28/21 BTIG
Sharecare initiated with a Buy at BTIG
YMAB Y-mAbs Therapeutics
$33.32 /

+0.25 (+0.76%)

TIL Instil Bio
$18.09 /

-0.78 (-4.13%)

SNDX Syndax
$18.84 /

+0.54 (+2.95%)

SHCR Sharecare
$8.17 /

+0.16 (+2.00%)

RYTM Rhythm Pharmaceuticals
$13.06 /

+0.07 (+0.54%)

RMD ResMed
$289.12 /

-6.46 (-2.19%)

RCM R1 RCM
$20.41 /

+0.285 (+1.42%)

OCDX Ortho Clinical Diagnostics
$18.72 /

+0.4 (+2.18%)

NSTG NanoString
$56.17 /

-3.51 (-5.88%)

KLDO Kaleido Biosciences
$5.53 /

-0.015 (-0.27%)

KDNY Chinook Therapeutics
$13.05 /

-0.04 (-0.31%)

IRTC iRhythm
$64.99 /

+16.465 (+33.93%)

HOLX Hologic
$78.49 /

-1.51 (-1.89%)

GH Guardant Health
$126.51 /

-2.58 (-2.00%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

CMPS Compass Pathways
$33.05 /

-1.24 (-3.62%)

AKBA Akebia
$2.92 /

+0.035 (+1.22%)

ACCD Accolade
$47.23 /

-0.1 (-0.21%)

ABC AmerisourceBergen
$123.66 /

+0.79 (+0.64%)

  • 10
    Sep
  • 10
    Jun
  • 27
    May
  • 30
    Apr
  • 19
    Mar
  • 18
    Feb
  • 04
    Feb
  • 05
    Feb
  • 28
    Jan
  • 09
    Dec
  • 22
    Oct
  • 23
    Oct
  • 07
    Oct
  • 08
    Oct
  • 18
    Sep
RDY Dr. Reddy's
$67.09 /

+1.18 (+1.79%)

IRTC iRhythm
$64.99 /

+16.465 (+33.93%)

CMPS Compass Pathways
$33.05 /

-1.24 (-3.62%)

ABC AmerisourceBergen
$123.66 /

+0.79 (+0.64%)

TIL Instil Bio
$18.09 /

-0.78 (-4.13%)

SNDX Syndax
$18.84 /

+0.54 (+2.95%)

RYTM Rhythm Pharmaceuticals
$13.06 /

+0.07 (+0.54%)

RMD ResMed
$289.12 /

-6.46 (-2.19%)

RCM R1 RCM
$20.41 /

+0.285 (+1.42%)

OCDX Ortho Clinical Diagnostics
$18.72 /

+0.4 (+2.18%)

KDNY Chinook Therapeutics
$13.05 /

-0.04 (-0.31%)

IRTC iRhythm
$64.99 /

+16.465 (+33.93%)

HOLX Hologic
$78.49 /

-1.51 (-1.89%)

GH Guardant Health
$126.51 /

-2.58 (-2.00%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

CMPS Compass Pathways
$33.05 /

-1.24 (-3.62%)

AKBA Akebia
$2.92 /

+0.035 (+1.22%)

ACCD Accolade
$47.23 /

-0.1 (-0.21%)

ABC AmerisourceBergen
$123.66 /

+0.79 (+0.64%)

SHCR Sharecare
$8.17 /

+0.16 (+2.00%)

RMD ResMed
$289.12 /

-6.46 (-2.19%)

HOLX Hologic
$78.49 /

-1.51 (-1.89%)

FHTX Foghorn Therapeutics
$12.67 /

-1.43 (-10.14%)

ACCD Accolade
$47.23 /

-0.1 (-0.21%)

ABC AmerisourceBergen
$123.66 /

+0.79 (+0.64%)

Conference/Events
Morgan Stanley to hold a virtual conference » 04:55
09/13/21
09/13
04:55
09/13/21
04:55
ABC

AmerisourceBergen

$122.87 /

-0.78 (-0.63%)

, ACCD

Accolade

$47.24 /

-0.68 (-1.42%)

, AKBA

Akebia

$2.88 /

-0.085 (-2.87%)

, CMPS

Compass Pathways

$34.34 /

-0.01 (-0.03%)

, GH

Guardant Health

$129.07 /

-1.87 (-1.43%)

, KLDO

Kaleido Biosciences

$5.53 /

-0.37 (-6.27%)

, YMAB

Y-mAbs Therapeutics

$33.05 /

+0.045 (+0.14%)

, RYTM

Rhythm Pharmaceuticals

$12.98 /

-0.05 (-0.38%)

, OCDX

Ortho Clinical Diagnostics

$18.32 /

+0.505 (+2.83%)

, KDNY

Chinook Therapeutics

$13.08 /

-0.18 (-1.36%)

, IRTC

iRhythm

$48.16 /

-0.59 (-1.21%)

, NSTG

NanoString

$59.68 /

+0.63 (+1.07%)

, RMD

ResMed

$295.21 /

-0.7 (-0.24%)

, RDY

Dr. Reddy's

$65.91 /

+0.16 (+0.24%)

, HOLX

Hologic

$80.00 /

+0.01 (+0.01%)

, EXEL

Exelixis

$19.99 /

+0.45 (+2.30%)

, FHTX

Foghorn Therapeutics

$13.96 /

+1.03 (+7.97%)

, MAYNF

Mayne Pharma

/

+

, RCM

R1 RCM

$20.13 /

+0.205 (+1.03%)

, TIL

Instil Bio

$18.66 /

-1.18 (-5.95%)

, SNDX

Syndax

$18.32 /

+0.21 (+1.16%)

, SHCR

Sharecare

$8.01 /

+0.515 (+6.87%)

19th Annual Global…

19th Annual Global Healthcare Virtual Conference to be held on September 9-10 and will resume on September 13-15. Webcast Link

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$33.05 /

+0.045 (+0.14%)

TIL Instil Bio
$18.66 /

-1.18 (-5.95%)

SNDX Syndax
$18.32 /

+0.21 (+1.16%)

SHCR Sharecare
$8.01 /

+0.515 (+6.87%)

RYTM Rhythm Pharmaceuticals
$12.98 /

-0.05 (-0.38%)

RMD ResMed
$295.21 /

-0.7 (-0.24%)

RDY Dr. Reddy's
$65.91 /

+0.16 (+0.24%)

RCM R1 RCM
$20.13 /

+0.205 (+1.03%)

OCDX Ortho Clinical Diagnostics
$18.32 /

+0.505 (+2.83%)

NSTG NanoString
$59.68 /

+0.63 (+1.07%)

KLDO Kaleido Biosciences
$5.53 /

-0.37 (-6.27%)

KDNY Chinook Therapeutics
$13.08 /

-0.18 (-1.36%)

IRTC iRhythm
$48.16 /

-0.59 (-1.21%)

HOLX Hologic
$80.00 /

+0.01 (+0.01%)

GH Guardant Health
$129.07 /

-1.87 (-1.43%)

FHTX Foghorn Therapeutics
$13.96 /

+1.03 (+7.97%)

EXEL Exelixis
$19.99 /

+0.45 (+2.30%)

CMPS Compass Pathways
$34.34 /

-0.01 (-0.03%)

AKBA Akebia
$2.88 /

-0.085 (-2.87%)

ACCD Accolade
$47.24 /

-0.68 (-1.42%)

ABC AmerisourceBergen
$122.87 /

-0.78 (-0.63%)

ABC AmerisourceBergen
$122.87 /

-0.78 (-0.63%)

08/27/21 Baird
AmerisourceBergen a table pounding top pick, says Baird
08/05/21 Credit Suisse
AmerisourceBergen price target raised to $144 from $132 at Credit Suisse
08/05/21 Baird
AmerisourceBergen price target raised to $162 from $156 at Baird
07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
ACCD Accolade
$47.24 /

-0.68 (-1.42%)

07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
07/09/21 Needham
Accolade price target raised to $68 from $59 at Needham
07/09/21 Stifel
Accolade price target raised to $64 from $54 at Stifel
07/09/21 Piper Sandler
Accolade has 'multiple beat-and-raise drivers,' says Piper Sandler
AKBA Akebia
$2.88 /

-0.085 (-2.87%)

07/15/21 Piper Sandler
Akebia approval path intact after FibroGen panel vote, says Piper Sandler
07/14/21 Morgan Stanley
FibroGen AdCom docs have likely read through for Akebia, says Morgan Stanley
06/01/21 H.C. Wainwright
Akebia NDA accepted with no FDA panel planned, says H.C. Wainwright
06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
CMPS Compass Pathways
$34.34 /

-0.01 (-0.03%)

07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$129.07 /

-1.87 (-1.43%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
KLDO Kaleido Biosciences
$5.53 /

-0.37 (-6.27%)

07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
YMAB Y-mAbs Therapeutics
$33.05 /

+0.045 (+0.14%)

06/28/21 H.C. Wainwright
Y-mAbs Therapeutics price target lowered to $68 from $70 at H.C. Wainwright
05/07/21 BofA
Y-mAbs Therapeutics upgraded to Buy from Neutral at BofA
04/23/21 Cowen
Y-mAbs Therapeutics transferred with Outperform at Cowen
04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
RYTM Rhythm Pharmaceuticals
$12.98 /

-0.05 (-0.38%)

08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Ladenburg
Rhythm Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
OCDX Ortho Clinical Diagnostics
$18.32 /

+0.505 (+2.83%)

08/05/21 Piper Sandler
Piper ups Ortho Clinical Diagnostics target to $29, says to buy on any weakness
08/05/21 JPMorgan
Ortho Clinical price target raised to $28 from $25 at JPMorgan
08/05/21 H.C. Wainwright
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright
08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
KDNY Chinook Therapeutics
$13.08 /

-0.18 (-1.36%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
IRTC iRhythm
$48.16 /

-0.59 (-1.21%)

08/26/21 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
08/06/21 Citi
iRhythm price target lowered to $55 from $74 at Citi
06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
NSTG NanoString
$59.68 /

+0.63 (+1.07%)

03/02/21 JPMorgan
NanoString price target raised to $80 from $75 at JPMorgan
03/02/21 Baird
NanoString price target raised to $78 from $70 at Baird
01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
RMD ResMed
$295.21 /

-0.7 (-0.24%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RDY Dr. Reddy's
$65.91 /

+0.16 (+0.24%)

07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral at Credit Suisse after Q1 report
07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Investec
Dr. Reddy's upgraded to Buy from Hold at Investec
02/02/21 Barclays
Dr. Reddy's upgraded to Overweight from Equal Weight at Barclays
HOLX Hologic
$80.00 /

+0.01 (+0.01%)

07/06/21 Evercore ISI
Evercore ISI upgrades Hologic to Outperform on visibility in base business
07/06/21 Evercore ISI
Hologic upgraded to Outperform from In Line at Evercore ISI
06/11/21 Citi
Hologic 15% selloff brings 'strong entry point,' says Citi
04/29/21 Citi
Hologic price target lowered to $80 from $90 at Citi
EXEL Exelixis
$19.99 /

+0.45 (+2.30%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FHTX Foghorn Therapeutics
$13.96 /

+1.03 (+7.97%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
MAYNF Mayne Pharma
/

+

08/30/21 Citi
Mayne Pharma upgraded to Buy from Neutral at Citi
RCM R1 RCM
$20.13 /

+0.205 (+1.03%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
TIL Instil Bio
$18.66 /

-1.18 (-5.95%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
SNDX Syndax
$18.32 /

+0.21 (+1.16%)

06/03/21 Baird
Syndax transferred with Outperform at Baird
05/25/21 Citi
Syndax initiated with a Buy at Citi
04/21/21 Baird
Syndax price target lowered to $30 from $39 at Baird
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
SHCR Sharecare
$8.01 /

+0.515 (+6.87%)

08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
08/04/21 Canaccord
Sharecare initiated with a Buy at Canaccord
07/28/21 BTIG
Sharecare initiated with a Buy at BTIG
YMAB Y-mAbs Therapeutics
$33.05 /

+0.045 (+0.14%)

TIL Instil Bio
$18.66 /

-1.18 (-5.95%)

SNDX Syndax
$18.32 /

+0.21 (+1.16%)

SHCR Sharecare
$8.01 /

+0.515 (+6.87%)

RYTM Rhythm Pharmaceuticals
$12.98 /

-0.05 (-0.38%)

RMD ResMed
$295.21 /

-0.7 (-0.24%)

RCM R1 RCM
$20.13 /

+0.205 (+1.03%)

OCDX Ortho Clinical Diagnostics
$18.32 /

+0.505 (+2.83%)

NSTG NanoString
$59.68 /

+0.63 (+1.07%)

KLDO Kaleido Biosciences
$5.53 /

-0.37 (-6.27%)

KDNY Chinook Therapeutics
$13.08 /

-0.18 (-1.36%)

IRTC iRhythm
$48.16 /

-0.59 (-1.21%)

HOLX Hologic
$80.00 /

+0.01 (+0.01%)

GH Guardant Health
$129.07 /

-1.87 (-1.43%)

EXEL Exelixis
$19.99 /

+0.45 (+2.30%)

CMPS Compass Pathways
$34.34 /

-0.01 (-0.03%)

AKBA Akebia
$2.88 /

-0.085 (-2.87%)

ACCD Accolade
$47.24 /

-0.68 (-1.42%)

ABC AmerisourceBergen
$122.87 /

-0.78 (-0.63%)

  • 10
    Sep
  • 10
    Jun
  • 27
    May
  • 30
    Apr
  • 19
    Mar
  • 18
    Feb
  • 04
    Feb
  • 05
    Feb
  • 28
    Jan
  • 09
    Dec
  • 22
    Oct
  • 23
    Oct
  • 07
    Oct
  • 08
    Oct
  • 18
    Sep
RDY Dr. Reddy's
$65.91 /

+0.16 (+0.24%)

IRTC iRhythm
$48.16 /

-0.59 (-1.21%)

CMPS Compass Pathways
$34.34 /

-0.01 (-0.03%)

ABC AmerisourceBergen
$122.87 /

-0.78 (-0.63%)

TIL Instil Bio
$18.66 /

-1.18 (-5.95%)

SNDX Syndax
$18.32 /

+0.21 (+1.16%)

RYTM Rhythm Pharmaceuticals
$12.98 /

-0.05 (-0.38%)

RMD ResMed
$295.21 /

-0.7 (-0.24%)

RCM R1 RCM
$20.13 /

+0.205 (+1.03%)

OCDX Ortho Clinical Diagnostics
$18.32 /

+0.505 (+2.83%)

KDNY Chinook Therapeutics
$13.08 /

-0.18 (-1.36%)

IRTC iRhythm
$48.16 /

-0.59 (-1.21%)

HOLX Hologic
$80.00 /

+0.01 (+0.01%)

GH Guardant Health
$129.07 /

-1.87 (-1.43%)

EXEL Exelixis
$19.99 /

+0.45 (+2.30%)

CMPS Compass Pathways
$34.34 /

-0.01 (-0.03%)

AKBA Akebia
$2.88 /

-0.085 (-2.87%)

ACCD Accolade
$47.24 /

-0.68 (-1.42%)

ABC AmerisourceBergen
$122.87 /

-0.78 (-0.63%)

SHCR Sharecare
$8.01 /

+0.515 (+6.87%)

RMD ResMed
$295.21 /

-0.7 (-0.24%)

HOLX Hologic
$80.00 /

+0.01 (+0.01%)

FHTX Foghorn Therapeutics
$13.96 /

+1.03 (+7.97%)

ACCD Accolade
$47.24 /

-0.68 (-1.42%)

ABC AmerisourceBergen
$122.87 /

-0.78 (-0.63%)

Conference/Events
Morgan Stanley to hold a virtual conference » 04:55
09/10/21
09/10
04:55
09/10/21
04:55
ABC

AmerisourceBergen

$123.61 /

-0.74 (-0.60%)

, ACCD

Accolade

$47.80 /

+0.68 (+1.44%)

, AKBA

Akebia

$2.97 /

+0.03 (+1.02%)

, CMPS

Compass Pathways

$34.35 /

+0.8 (+2.38%)

, GH

Guardant Health

$130.99 /

+0.96 (+0.74%)

, KLDO

Kaleido Biosciences

$5.93 /

+0.035 (+0.59%)

, YMAB

Y-mAbs Therapeutics

$32.93 /

+1.03 (+3.23%)

, RYTM

Rhythm Pharmaceuticals

$13.01 /

+0.17 (+1.32%)

, OCDX

Ortho Clinical Diagnostics

$17.82 /

-1.83 (-9.31%)

, KDNY

Chinook Therapeutics

$13.26 /

-0.29 (-2.14%)

, IRTC

iRhythm

$48.65 /

+1.19 (+2.51%)

, NSTG

NanoString

$59.05 /

+0.24 (+0.41%)

, RMD

ResMed

$295.55 /

-1.95 (-0.66%)

, RDY

Dr. Reddy's

$65.78 /

-0.12 (-0.18%)

, HOLX

Hologic

$79.99 /

-0.725 (-0.90%)

, EXEL

Exelixis

$19.54 /

-0.34 (-1.71%)

, FHTX

Foghorn Therapeutics

$12.96 /

+0.06 (+0.47%)

, MAYNF

Mayne Pharma

/

+

, RCM

R1 RCM

$19.92 /

+0.53 (+2.73%)

, TIL

Instil Bio

$19.78 /

+0.07 (+0.36%)

, SNDX

Syndax

$18.08 /

+0.38 (+2.15%)

, SHCR

Sharecare

$7.49 /

+0.64 (+9.34%)

19th Annual Global…

19th Annual Global Healthcare Virtual Conference to be held on September 9-10 and will resume on September 13-15. Webcast Link

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$32.93 /

+1.03 (+3.23%)

TIL Instil Bio
$19.78 /

+0.07 (+0.36%)

SNDX Syndax
$18.08 /

+0.38 (+2.15%)

SHCR Sharecare
$7.49 /

+0.64 (+9.34%)

RYTM Rhythm Pharmaceuticals
$13.01 /

+0.17 (+1.32%)

RMD ResMed
$295.55 /

-1.95 (-0.66%)

RDY Dr. Reddy's
$65.78 /

-0.12 (-0.18%)

RCM R1 RCM
$19.92 /

+0.53 (+2.73%)

OCDX Ortho Clinical Diagnostics
$17.82 /

-1.83 (-9.31%)

NSTG NanoString
$59.05 /

+0.24 (+0.41%)

KLDO Kaleido Biosciences
$5.93 /

+0.035 (+0.59%)

KDNY Chinook Therapeutics
$13.26 /

-0.29 (-2.14%)

IRTC iRhythm
$48.65 /

+1.19 (+2.51%)

HOLX Hologic
$79.99 /

-0.725 (-0.90%)

GH Guardant Health
$130.99 /

+0.96 (+0.74%)

FHTX Foghorn Therapeutics
$12.96 /

+0.06 (+0.47%)

EXEL Exelixis
$19.54 /

-0.34 (-1.71%)

CMPS Compass Pathways
$34.35 /

+0.8 (+2.38%)

AKBA Akebia
$2.97 /

+0.03 (+1.02%)

ACCD Accolade
$47.80 /

+0.68 (+1.44%)

ABC AmerisourceBergen
$123.61 /

-0.74 (-0.60%)

ABC AmerisourceBergen
$123.61 /

-0.74 (-0.60%)

08/27/21 Baird
AmerisourceBergen a table pounding top pick, says Baird
08/05/21 Credit Suisse
AmerisourceBergen price target raised to $144 from $132 at Credit Suisse
08/05/21 Baird
AmerisourceBergen price target raised to $162 from $156 at Baird
07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
ACCD Accolade
$47.80 /

+0.68 (+1.44%)

07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
07/09/21 Needham
Accolade price target raised to $68 from $59 at Needham
07/09/21 Stifel
Accolade price target raised to $64 from $54 at Stifel
07/09/21 Piper Sandler
Accolade has 'multiple beat-and-raise drivers,' says Piper Sandler
AKBA Akebia
$2.97 /

+0.03 (+1.02%)

07/15/21 Piper Sandler
Akebia approval path intact after FibroGen panel vote, says Piper Sandler
07/14/21 Morgan Stanley
FibroGen AdCom docs have likely read through for Akebia, says Morgan Stanley
06/01/21 H.C. Wainwright
Akebia NDA accepted with no FDA panel planned, says H.C. Wainwright
06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
CMPS Compass Pathways
$34.35 /

+0.8 (+2.38%)

07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$130.99 /

+0.96 (+0.74%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
KLDO Kaleido Biosciences
$5.93 /

+0.035 (+0.59%)

07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
YMAB Y-mAbs Therapeutics
$32.93 /

+1.03 (+3.23%)

06/28/21 H.C. Wainwright
Y-mAbs Therapeutics price target lowered to $68 from $70 at H.C. Wainwright
05/07/21 BofA
Y-mAbs Therapeutics upgraded to Buy from Neutral at BofA
04/23/21 Cowen
Y-mAbs Therapeutics transferred with Outperform at Cowen
04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
RYTM Rhythm Pharmaceuticals
$13.01 /

+0.17 (+1.32%)

08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Ladenburg
Rhythm Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
OCDX Ortho Clinical Diagnostics
$17.82 /

-1.83 (-9.31%)

08/05/21 Piper Sandler
Piper ups Ortho Clinical Diagnostics target to $29, says to buy on any weakness
08/05/21 JPMorgan
Ortho Clinical price target raised to $28 from $25 at JPMorgan
08/05/21 H.C. Wainwright
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright
08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
KDNY Chinook Therapeutics
$13.26 /

-0.29 (-2.14%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
IRTC iRhythm
$48.65 /

+1.19 (+2.51%)

08/26/21 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
08/06/21 Citi
iRhythm price target lowered to $55 from $74 at Citi
06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
NSTG NanoString
$59.05 /

+0.24 (+0.41%)

03/02/21 JPMorgan
NanoString price target raised to $80 from $75 at JPMorgan
03/02/21 Baird
NanoString price target raised to $78 from $70 at Baird
01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
RMD ResMed
$295.55 /

-1.95 (-0.66%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RDY Dr. Reddy's
$65.78 /

-0.12 (-0.18%)

07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral at Credit Suisse after Q1 report
07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Investec
Dr. Reddy's upgraded to Buy from Hold at Investec
02/02/21 Barclays
Dr. Reddy's upgraded to Overweight from Equal Weight at Barclays
HOLX Hologic
$79.99 /

-0.725 (-0.90%)

07/06/21 Evercore ISI
Evercore ISI upgrades Hologic to Outperform on visibility in base business
07/06/21 Evercore ISI
Hologic upgraded to Outperform from In Line at Evercore ISI
06/11/21 Citi
Hologic 15% selloff brings 'strong entry point,' says Citi
04/29/21 Citi
Hologic price target lowered to $80 from $90 at Citi
EXEL Exelixis
$19.54 /

-0.34 (-1.71%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FHTX Foghorn Therapeutics
$12.96 /

+0.06 (+0.47%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
MAYNF Mayne Pharma
/

+

08/30/21 Citi
Mayne Pharma upgraded to Buy from Neutral at Citi
RCM R1 RCM
$19.92 /

+0.53 (+2.73%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
TIL Instil Bio
$19.78 /

+0.07 (+0.36%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
SNDX Syndax
$18.08 /

+0.38 (+2.15%)

06/03/21 Baird
Syndax transferred with Outperform at Baird
05/25/21 Citi
Syndax initiated with a Buy at Citi
04/21/21 Baird
Syndax price target lowered to $30 from $39 at Baird
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
SHCR Sharecare
$7.49 /

+0.64 (+9.34%)

08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
08/04/21 Canaccord
Sharecare initiated with a Buy at Canaccord
07/28/21 BTIG
Sharecare initiated with a Buy at BTIG
YMAB Y-mAbs Therapeutics
$32.93 /

+1.03 (+3.23%)

TIL Instil Bio
$19.78 /

+0.07 (+0.36%)

SNDX Syndax
$18.08 /

+0.38 (+2.15%)

SHCR Sharecare
$7.49 /

+0.64 (+9.34%)

RYTM Rhythm Pharmaceuticals
$13.01 /

+0.17 (+1.32%)

RMD ResMed
$295.55 /

-1.95 (-0.66%)

RCM R1 RCM
$19.92 /

+0.53 (+2.73%)

OCDX Ortho Clinical Diagnostics
$17.82 /

-1.83 (-9.31%)

NSTG NanoString
$59.05 /

+0.24 (+0.41%)

KLDO Kaleido Biosciences
$5.93 /

+0.035 (+0.59%)

KDNY Chinook Therapeutics
$13.26 /

-0.29 (-2.14%)

IRTC iRhythm
$48.65 /

+1.19 (+2.51%)

HOLX Hologic
$79.99 /

-0.725 (-0.90%)

GH Guardant Health
$130.99 /

+0.96 (+0.74%)

EXEL Exelixis
$19.54 /

-0.34 (-1.71%)

CMPS Compass Pathways
$34.35 /

+0.8 (+2.38%)

AKBA Akebia
$2.97 /

+0.03 (+1.02%)

ACCD Accolade
$47.80 /

+0.68 (+1.44%)

ABC AmerisourceBergen
$123.61 /

-0.74 (-0.60%)

  • 10
    Sep
  • 10
    Jun
  • 27
    May
  • 30
    Apr
  • 19
    Mar
  • 18
    Feb
  • 04
    Feb
  • 05
    Feb
  • 28
    Jan
  • 09
    Dec
  • 22
    Oct
  • 23
    Oct
  • 07
    Oct
  • 08
    Oct
  • 18
    Sep
YMAB Y-mAbs Therapeutics
$32.93 /

+1.03 (+3.23%)

RDY Dr. Reddy's
$65.78 /

-0.12 (-0.18%)

IRTC iRhythm
$48.65 /

+1.19 (+2.51%)

CMPS Compass Pathways
$34.35 /

+0.8 (+2.38%)

ABC AmerisourceBergen
$123.61 /

-0.74 (-0.60%)

TIL Instil Bio
$19.78 /

+0.07 (+0.36%)

SNDX Syndax
$18.08 /

+0.38 (+2.15%)

RYTM Rhythm Pharmaceuticals
$13.01 /

+0.17 (+1.32%)

RMD ResMed
$295.55 /

-1.95 (-0.66%)

RCM R1 RCM
$19.92 /

+0.53 (+2.73%)

OCDX Ortho Clinical Diagnostics
$17.82 /

-1.83 (-9.31%)

KDNY Chinook Therapeutics
$13.26 /

-0.29 (-2.14%)

IRTC iRhythm
$48.65 /

+1.19 (+2.51%)

HOLX Hologic
$79.99 /

-0.725 (-0.90%)

GH Guardant Health
$130.99 /

+0.96 (+0.74%)

EXEL Exelixis
$19.54 /

-0.34 (-1.71%)

CMPS Compass Pathways
$34.35 /

+0.8 (+2.38%)

AKBA Akebia
$2.97 /

+0.03 (+1.02%)

ACCD Accolade
$47.80 /

+0.68 (+1.44%)

ABC AmerisourceBergen
$123.61 /

-0.74 (-0.60%)

SHCR Sharecare
$7.49 /

+0.64 (+9.34%)

RMD ResMed
$295.55 /

-1.95 (-0.66%)

KDNY Chinook Therapeutics
$13.26 /

-0.29 (-2.14%)

HOLX Hologic
$79.99 /

-0.725 (-0.90%)

FHTX Foghorn Therapeutics
$12.96 /

+0.06 (+0.47%)

ACCD Accolade
$47.80 /

+0.68 (+1.44%)

ABC AmerisourceBergen
$123.61 /

-0.74 (-0.60%)

Conference/Events
Morgan Stanley to hold a virtual conference » 04:55
09/09/21
09/09
04:55
09/09/21
04:55
ABC

AmerisourceBergen

$124.30 /

+0.065 (+0.05%)

, ACCD

Accolade

$47.12 /

-1.07 (-2.22%)

, AKBA

Akebia

$2.94 /

-0.04 (-1.34%)

, CMPS

Compass Pathways

$33.55 /

-0.83 (-2.41%)

, GH

Guardant Health

$129.96 /

-2.16 (-1.63%)

, KLDO

Kaleido Biosciences

$5.91 /

-0.14 (-2.31%)

, YMAB

Y-mAbs Therapeutics

$31.90 /

+0.28 (+0.89%)

, RYTM

Rhythm Pharmaceuticals

$12.84 /

-0.29 (-2.21%)

, OCDX

Ortho Clinical Diagnostics

$19.65 /

-0.95 (-4.61%)

, KDNY

Chinook Therapeutics

$13.55 /

+0.06 (+0.44%)

, IRTC

iRhythm

$47.46 /

-0.51 (-1.06%)

, NSTG

NanoString

$58.68 /

-0.45 (-0.76%)

, RMD

ResMed

$297.39 /

+1.32 (+0.45%)

, RDY

Dr. Reddy's

$66.22 /

-0.23 (-0.35%)

, HOLX

Hologic

$80.72 /

+0.9 (+1.13%)

, EXEL

Exelixis

$19.88 /

+0.355 (+1.82%)

, FHTX

Foghorn Therapeutics

$12.75 /

-0.49 (-3.70%)

, MAYNF

Mayne Pharma

/

+

, RCM

R1 RCM

$19.39 /

-0.6 (-3.00%)

, TIL

Instil Bio

$19.63 /

-1.34 (-6.39%)

, SNDX

Syndax

$17.75 /

+0.595 (+3.47%)

, SHCR

Sharecare

$6.82 /

-0.345 (-4.82%)

19th Annual Global…

19th Annual Global Healthcare Virtual Conference to be held on September 9-10 and will resume on September 13-15. Webcast Link

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

SNDX Syndax
$17.75 /

+0.595 (+3.47%)

SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

RDY Dr. Reddy's
$66.22 /

-0.23 (-0.35%)

RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

NSTG NanoString
$58.68 /

-0.45 (-0.76%)

KLDO Kaleido Biosciences
$5.91 /

-0.14 (-2.31%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

GH Guardant Health
$129.96 /

-2.16 (-1.63%)

FHTX Foghorn Therapeutics
$12.75 /

-0.49 (-3.70%)

EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

AKBA Akebia
$2.94 /

-0.04 (-1.34%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

08/27/21 Baird
AmerisourceBergen a table pounding top pick, says Baird
08/05/21 Credit Suisse
AmerisourceBergen price target raised to $144 from $132 at Credit Suisse
08/05/21 Baird
AmerisourceBergen price target raised to $162 from $156 at Baird
07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
ACCD Accolade
$47.12 /

-1.07 (-2.22%)

07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
07/09/21 Needham
Accolade price target raised to $68 from $59 at Needham
07/09/21 Stifel
Accolade price target raised to $64 from $54 at Stifel
07/09/21 Piper Sandler
Accolade has 'multiple beat-and-raise drivers,' says Piper Sandler
AKBA Akebia
$2.94 /

-0.04 (-1.34%)

07/15/21 Piper Sandler
Akebia approval path intact after FibroGen panel vote, says Piper Sandler
07/14/21 Morgan Stanley
FibroGen AdCom docs have likely read through for Akebia, says Morgan Stanley
06/01/21 H.C. Wainwright
Akebia NDA accepted with no FDA panel planned, says H.C. Wainwright
06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$129.96 /

-2.16 (-1.63%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
KLDO Kaleido Biosciences
$5.91 /

-0.14 (-2.31%)

07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

06/28/21 H.C. Wainwright
Y-mAbs Therapeutics price target lowered to $68 from $70 at H.C. Wainwright
05/07/21 BofA
Y-mAbs Therapeutics upgraded to Buy from Neutral at BofA
04/23/21 Cowen
Y-mAbs Therapeutics transferred with Outperform at Cowen
04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Ladenburg
Rhythm Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

08/05/21 Piper Sandler
Piper ups Ortho Clinical Diagnostics target to $29, says to buy on any weakness
08/05/21 JPMorgan
Ortho Clinical price target raised to $28 from $25 at JPMorgan
08/05/21 H.C. Wainwright
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright
08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

08/26/21 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
08/06/21 Citi
iRhythm price target lowered to $55 from $74 at Citi
06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
NSTG NanoString
$58.68 /

-0.45 (-0.76%)

03/02/21 JPMorgan
NanoString price target raised to $80 from $75 at JPMorgan
03/02/21 Baird
NanoString price target raised to $78 from $70 at Baird
01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
RMD ResMed
$297.39 /

+1.32 (+0.45%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RDY Dr. Reddy's
$66.22 /

-0.23 (-0.35%)

07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral at Credit Suisse after Q1 report
07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Investec
Dr. Reddy's upgraded to Buy from Hold at Investec
02/02/21 Barclays
Dr. Reddy's upgraded to Overweight from Equal Weight at Barclays
HOLX Hologic
$80.72 /

+0.9 (+1.13%)

07/06/21 Evercore ISI
Evercore ISI upgrades Hologic to Outperform on visibility in base business
07/06/21 Evercore ISI
Hologic upgraded to Outperform from In Line at Evercore ISI
06/11/21 Citi
Hologic 15% selloff brings 'strong entry point,' says Citi
04/29/21 Citi
Hologic price target lowered to $80 from $90 at Citi
EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FHTX Foghorn Therapeutics
$12.75 /

-0.49 (-3.70%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
MAYNF Mayne Pharma
/

+

08/30/21 Citi
Mayne Pharma upgraded to Buy from Neutral at Citi
RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
SNDX Syndax
$17.75 /

+0.595 (+3.47%)

06/03/21 Baird
Syndax transferred with Outperform at Baird
05/25/21 Citi
Syndax initiated with a Buy at Citi
04/21/21 Baird
Syndax price target lowered to $30 from $39 at Baird
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
08/04/21 Canaccord
Sharecare initiated with a Buy at Canaccord
07/28/21 BTIG
Sharecare initiated with a Buy at BTIG
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

SNDX Syndax
$17.75 /

+0.595 (+3.47%)

SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

NSTG NanoString
$58.68 /

-0.45 (-0.76%)

KLDO Kaleido Biosciences
$5.91 /

-0.14 (-2.31%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

GH Guardant Health
$129.96 /

-2.16 (-1.63%)

EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

AKBA Akebia
$2.94 /

-0.04 (-1.34%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

  • 10
    Sep
  • 10
    Jun
  • 27
    May
  • 30
    Apr
  • 19
    Mar
  • 18
    Feb
  • 04
    Feb
  • 05
    Feb
  • 28
    Jan
  • 09
    Dec
  • 22
    Oct
  • 23
    Oct
  • 07
    Oct
  • 08
    Oct
  • 18
    Sep
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

RDY Dr. Reddy's
$66.22 /

-0.23 (-0.35%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

SNDX Syndax
$17.75 /

+0.595 (+3.47%)

RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

GH Guardant Health
$129.96 /

-2.16 (-1.63%)

EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

AKBA Akebia
$2.94 /

-0.04 (-1.34%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

FHTX Foghorn Therapeutics
$12.75 /

-0.49 (-3.70%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

Conference/Events
Morgan Stanley to hold a virtual conference » 17:19
09/08/21
09/08
17:19
09/08/21
17:19
ABC

AmerisourceBergen

$124.30 /

+0.065 (+0.05%)

, ACCD

Accolade

$47.12 /

-1.07 (-2.22%)

, AKBA

Akebia

$2.94 /

-0.04 (-1.34%)

, CMPS

Compass Pathways

$33.55 /

-0.83 (-2.41%)

, GH

Guardant Health

$129.96 /

-2.16 (-1.63%)

, KLDO

Kaleido Biosciences

$5.91 /

-0.14 (-2.31%)

, YMAB

Y-mAbs Therapeutics

$31.90 /

+0.28 (+0.89%)

, RYTM

Rhythm Pharmaceuticals

$12.84 /

-0.29 (-2.21%)

, OCDX

Ortho Clinical Diagnostics

$19.65 /

-0.95 (-4.61%)

, KDNY

Chinook Therapeutics

$13.55 /

+0.06 (+0.44%)

, IRTC

iRhythm

$47.46 /

-0.51 (-1.06%)

, NSTG

NanoString

$58.68 /

-0.45 (-0.76%)

, RMD

ResMed

$297.39 /

+1.32 (+0.45%)

, RDY

Dr. Reddy's

$66.22 /

-0.23 (-0.35%)

, HOLX

Hologic

$80.72 /

+0.9 (+1.13%)

, EXEL

Exelixis

$19.88 /

+0.355 (+1.82%)

, FHTX

Foghorn Therapeutics

$12.75 /

-0.49 (-3.70%)

, MAYNF

Mayne Pharma

/

+

, RCM

R1 RCM

$19.39 /

-0.6 (-3.00%)

, TIL

Instil Bio

$19.63 /

-1.34 (-6.39%)

, SNDX

Syndax

$17.75 /

+0.595 (+3.47%)

, SHCR

Sharecare

$6.82 /

-0.345 (-4.82%)

19th Annual Global…

19th Annual Global Healthcare Virtual Conference to be held on September 9-10 and will resume on September 13-15. Webcast Link

ShowHide Related Items >><<
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

SNDX Syndax
$17.75 /

+0.595 (+3.47%)

SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

RDY Dr. Reddy's
$66.22 /

-0.23 (-0.35%)

RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

NSTG NanoString
$58.68 /

-0.45 (-0.76%)

KLDO Kaleido Biosciences
$5.91 /

-0.14 (-2.31%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

GH Guardant Health
$129.96 /

-2.16 (-1.63%)

FHTX Foghorn Therapeutics
$12.75 /

-0.49 (-3.70%)

EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

AKBA Akebia
$2.94 /

-0.04 (-1.34%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

08/27/21 Baird
AmerisourceBergen a table pounding top pick, says Baird
08/05/21 Credit Suisse
AmerisourceBergen price target raised to $144 from $132 at Credit Suisse
08/05/21 Baird
AmerisourceBergen price target raised to $162 from $156 at Baird
07/20/21 Jefferies
Report of $21B opioid settlement positive for drug distributors, says Jefferies
ACCD Accolade
$47.12 /

-1.07 (-2.22%)

07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
07/09/21 Needham
Accolade price target raised to $68 from $59 at Needham
07/09/21 Stifel
Accolade price target raised to $64 from $54 at Stifel
07/09/21 Piper Sandler
Accolade has 'multiple beat-and-raise drivers,' says Piper Sandler
AKBA Akebia
$2.94 /

-0.04 (-1.34%)

07/15/21 Piper Sandler
Akebia approval path intact after FibroGen panel vote, says Piper Sandler
07/14/21 Morgan Stanley
FibroGen AdCom docs have likely read through for Akebia, says Morgan Stanley
06/01/21 H.C. Wainwright
Akebia NDA accepted with no FDA panel planned, says H.C. Wainwright
06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

07/13/21
Fly Intel: Top five analyst initiations
07/13/21 Citi
Compass Pathways initiated with a Buy at Citi
07/01/21 H.C. Wainwright
Compass Pathways price target raised to $100 from $65 at H.C. Wainwright
06/28/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$129.96 /

-2.16 (-1.63%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
KLDO Kaleido Biosciences
$5.91 /

-0.14 (-2.31%)

07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
07/09/21 Chardan
Kaleido Biosciences assumed with a Buy at Chardan
02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

06/28/21 H.C. Wainwright
Y-mAbs Therapeutics price target lowered to $68 from $70 at H.C. Wainwright
05/07/21 BofA
Y-mAbs Therapeutics upgraded to Buy from Neutral at BofA
04/23/21 Cowen
Y-mAbs Therapeutics transferred with Outperform at Cowen
04/21/21 Wedbush
Y-mAbs Therapeutics price target lowered to $52 from $67 at Wedbush
RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Ladenburg
Rhythm Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

08/05/21 Piper Sandler
Piper ups Ortho Clinical Diagnostics target to $29, says to buy on any weakness
08/05/21 JPMorgan
Ortho Clinical price target raised to $28 from $25 at JPMorgan
08/05/21 H.C. Wainwright
Ortho Clinical Diagnostics price target raised to $30 from $27 at H.C. Wainwright
08/04/21 Credit Suisse
Ortho Clinical Diagnostics assumed with an Outperform at Credit Suisse
KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
01/06/21
Fly Intel: Top five analyst initiations
01/06/21 Wedbush
Wedbush bullish on Chinook Therapeutics, initiates with an Outperform
IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

08/26/21 Canaccord
iRhythm price target raised to $236 from $210 at Canaccord
08/06/21 Citi
iRhythm price target lowered to $55 from $74 at Citi
06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
NSTG NanoString
$58.68 /

-0.45 (-0.76%)

03/02/21 JPMorgan
NanoString price target raised to $80 from $75 at JPMorgan
03/02/21 Baird
NanoString price target raised to $78 from $70 at Baird
01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
RMD ResMed
$297.39 /

+1.32 (+0.45%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RDY Dr. Reddy's
$66.22 /

-0.23 (-0.35%)

07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral at Credit Suisse after Q1 report
07/27/21 Credit Suisse
Dr. Reddy's downgraded to Neutral from Outperform at Credit Suisse
02/03/21 Investec
Dr. Reddy's upgraded to Buy from Hold at Investec
02/02/21 Barclays
Dr. Reddy's upgraded to Overweight from Equal Weight at Barclays
HOLX Hologic
$80.72 /

+0.9 (+1.13%)

07/06/21 Evercore ISI
Evercore ISI upgrades Hologic to Outperform on visibility in base business
07/06/21 Evercore ISI
Hologic upgraded to Outperform from In Line at Evercore ISI
06/11/21 Citi
Hologic 15% selloff brings 'strong entry point,' says Citi
04/29/21 Citi
Hologic price target lowered to $80 from $90 at Citi
EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FHTX Foghorn Therapeutics
$12.75 /

-0.49 (-3.70%)

11/17/20 Morgan Stanley
Foghorn Therapeutics initiated with an Overweight at Morgan Stanley
11/17/20 Wedbush
Wedbush bullish on Foghorn Therapeutics, initiates with an Outperform
11/17/20 Wedbush
Foghorn Therapeutics initiated with an Outperform at Wedbush
11/17/20 Cowen
Foghorn Therapeutics initiated with an Outperform at Cowen
MAYNF Mayne Pharma
/

+

08/30/21 Citi
Mayne Pharma upgraded to Buy from Neutral at Citi
RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

07/22/21
Fly Intel: Top five analyst initiations
07/22/21 BofA
BofA starts R1 RCM at Buy, sees 32% upside potential
07/22/21 BofA
R1 RCM initiated with a Buy at BofA
06/02/21 Baird
R1 RCM initiated with an Outperform at Baird
TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
05/19/21 Chardan
Iovance Biotherapeutics price target lowered to $51 from $54 at Chardan
SNDX Syndax
$17.75 /

+0.595 (+3.47%)

06/03/21 Baird
Syndax transferred with Outperform at Baird
05/25/21 Citi
Syndax initiated with a Buy at Citi
04/21/21 Baird
Syndax price target lowered to $30 from $39 at Baird
02/24/21 Piper Sandler
Kura Oncology price target lowered to $30 from $34 at Piper Sandler
SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
08/04/21 Canaccord
Sharecare initiated with a Buy at Canaccord
07/28/21 BTIG
Sharecare initiated with a Buy at BTIG
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

SNDX Syndax
$17.75 /

+0.595 (+3.47%)

SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

NSTG NanoString
$58.68 /

-0.45 (-0.76%)

KLDO Kaleido Biosciences
$5.91 /

-0.14 (-2.31%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

GH Guardant Health
$129.96 /

-2.16 (-1.63%)

EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

AKBA Akebia
$2.94 /

-0.04 (-1.34%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

  • 10
    Sep
  • 10
    Jun
  • 27
    May
  • 30
    Apr
  • 19
    Mar
  • 18
    Feb
  • 04
    Feb
  • 05
    Feb
  • 28
    Jan
  • 09
    Dec
  • 22
    Oct
  • 23
    Oct
  • 07
    Oct
  • 08
    Oct
  • 18
    Sep
YMAB Y-mAbs Therapeutics
$31.90 /

+0.28 (+0.89%)

RDY Dr. Reddy's
$66.22 /

-0.23 (-0.35%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

TIL Instil Bio
$19.63 /

-1.34 (-6.39%)

SNDX Syndax
$17.75 /

+0.595 (+3.47%)

RYTM Rhythm Pharmaceuticals
$12.84 /

-0.29 (-2.21%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

RCM R1 RCM
$19.39 /

-0.6 (-3.00%)

OCDX Ortho Clinical Diagnostics
$19.65 /

-0.95 (-4.61%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

IRTC iRhythm
$47.46 /

-0.51 (-1.06%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

GH Guardant Health
$129.96 /

-2.16 (-1.63%)

EXEL Exelixis
$19.88 /

+0.355 (+1.82%)

CMPS Compass Pathways
$33.55 /

-0.83 (-2.41%)

AKBA Akebia
$2.94 /

-0.04 (-1.34%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

SHCR Sharecare
$6.82 /

-0.345 (-4.82%)

RMD ResMed
$297.39 /

+1.32 (+0.45%)

KDNY Chinook Therapeutics
$13.55 /

+0.06 (+0.44%)

HOLX Hologic
$80.72 /

+0.9 (+1.13%)

FHTX Foghorn Therapeutics
$12.75 /

-0.49 (-3.70%)

ACCD Accolade
$47.12 /

-1.07 (-2.22%)

ABC AmerisourceBergen
$124.30 /

+0.065 (+0.05%)

Hot Stocks
ResMed-supported study shows sleep apnea patients live longer on CPAP » 06:56
09/08/21
09/08
06:56
09/08/21
06:56
RMD

ResMed

$296.07 /

+0.14 (+0.05%)

ResMed announced the…

ResMed announced the presentation of a late-breaking abstract at the virtual European Respiratory Society International Congress 2021 supported by ResMed which states that using PAP - positive airway pressure - therapy as directed can significantly increase sleep apnea patients' chances of living longer. The ALASKA study, "CPAP Termination and All-Cause Mortality: a French Nationwide Database Analysis," concluded people with obstructive sleep apnea who continued PAP therapy were 39% more likely to survive than OSA patients who didn't. Researchers observed over 176,000 people in France with sleep apnea over a three-year period. Study authors say the survival rate gap remained significant when accounting for patients' ages, overall health, other pre-existing conditions, and causes of death. An estimated 936 million people worldwide have sleep apnea but over 80% remain undiagnosed.

ShowHide Related Items >><<
RMD ResMed
$296.07 /

+0.14 (+0.05%)

RMD ResMed
$296.07 /

+0.14 (+0.05%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RMD ResMed
$296.07 /

+0.14 (+0.05%)

RMD ResMed
$296.07 /

+0.14 (+0.05%)

RMD ResMed
$296.07 /

+0.14 (+0.05%)

Over a month ago
Hot Stocks
ResMed launches AirSense 11 PAP series, advancing digital health » 09:08
08/16/21
08/16
09:08
08/16/21
09:08
RMD

ResMed

$275.19 /

-0.15 (-0.05%)

ResMed launched AirSense…

ResMed launched AirSense 11, available first in the U.S., the company's next-generation PAP, or positive airway pressure, device designed to help people worldwide with sleep apnea start and stay on therapy to treat and manage obstructive sleep apnea. AirSense 11 includes new features like Personal Therapy Assistant and Care Check-In designed to provide tailored guidance to PAP users, helping ease them into therapy and comfortable nightly use. Other features include the availability of remote software updates so users can enjoy the latest version of these tools every night.

ShowHide Related Items >><<
RMD ResMed
$275.19 /

-0.15 (-0.05%)

08/09/21 CLSA
ResMed upgraded to Underperform from Sell at CLSA
08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
RMD ResMed
$275.19 /

-0.15 (-0.05%)

RMD ResMed
$275.19 /

-0.15 (-0.05%)

RMD ResMed
$275.19 /

-0.15 (-0.05%)

Upgrade
ResMed upgraded to Underperform from Sell at CLSA » 05:51
08/09/21
08/09
05:51
08/09/21
05:51
RMD

ResMed

$274.66 /

+7.29 (+2.73%)

CLSA analyst Andrew Paine…

CLSA analyst Andrew Paine upgraded ResMed (RMD) to Underperform from Sell with a A$38.70 price target as he raised his FY22 and FY23 view following the company's Q4 report to account for more clarity on market-share gains driven by Philips' (PHG) recall.

ShowHide Related Items >><<
RMD ResMed
$274.66 /

+7.29 (+2.73%)

08/08/21 Macquarie
ResMed downgraded to Neutral from Outperform at Macquarie
08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
08/02/21 Needham
ResMed downgraded to Hold from Buy at Needham
RMD ResMed
$274.66 /

+7.29 (+2.73%)

RMD ResMed
$274.66 /

+7.29 (+2.73%)

RMD ResMed
$274.66 /

+7.29 (+2.73%)

Downgrade
ResMed downgraded to Neutral from Outperform at Macquarie » 21:54
08/08/21
08/08
21:54
08/08/21
21:54
RMD

ResMed

$274.66 /

+7.29 (+2.73%)

Macquarie analyst David…

Macquarie analyst David Bailey downgraded ResMed to Neutral from Outperform with a A$37.50 price target.

ShowHide Related Items >><<
RMD ResMed
$274.66 /

+7.29 (+2.73%)

08/02/21 CLSA
ResMed downgraded to Sell from Outperform at CLSA
08/02/21 Needham
ResMed downgraded to Hold at Needham on valuation
08/02/21 Needham
ResMed downgraded to Hold from Buy at Needham
07/28/21
Fly Intel: Top five analyst upgrades
RMD ResMed
$274.66 /

+7.29 (+2.73%)

RMD ResMed
$274.66 /

+7.29 (+2.73%)

RMD ResMed
$274.66 /

+7.29 (+2.73%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.